Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
HitGen Announces Drug Discovery Research Agreement with ARase Therapeutics
Shanghai Stock Exchange-listed company HitGen announced today that it has entered into a research agreement […]
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer
Lucy Therapeutics, a private biotech company developing proprietary mitochondrial-based small molecule therapies and biomarkers for […]
Meliora Therapeutics Appoints Claudio Chuaqui as Head of Drug Discovery
Meliora Therapeutics, a biotech company pioneering a machine learning-driven approach to mechanism-driven oncology drug development, […]
Massive Bio and NeoGenomics Announce Collaboration to Accelerate Oncology Drug Discovery and Improve Patient Care
Massive Bio, a private AI-enabled oncology startup that provides virtual and in-person concierge services for […]
Synthego Introduces CRISPR Discovery Partners to Streamline CRISPR-Driven Drug Discovery Research
Synthego, a leading genome engineering solutions provider, announced today the launch of its service partner […]
Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease
UCB, a global biopharmaceutical company, and Aitia, the leader in the application of Causal AI […]
Neochromosome and Sumitovant Biopharma Announce Successful Collaboration to Accelerate Protein Drug Discovery and Improve Manufacturing
Neochromosome, a wholly owned subsidiary of Opentrons Labworks, focused on changing the world of biologics […]
Scenic Biotech Strengthens Drug Discovery Expertise in Management Team with the Addition of Kristof Van Emelen
Scenic Biotech, a pioneer in the discovery of genetic modifiers developing therapeutics to treat severe […]
Sosei Heptares and Lilly Enter Multi-target Collaboration and License Agreement in Diabetes and Metabolic Diseases
Sosei Group Corporation announces it has entered a drug discovery collaboration with Eli Lilly and […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more